BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 20606322)

  • 1. Ornithine and tryptophan analogs as efficient polycations for short interference RNA delivery to tumor cells.
    Sato Y; Hatakeyama H; Harashima H
    Biol Pharm Bull; 2010; 33(7):1246-9. PubMed ID: 20606322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Octaarginine-modified multifunctional envelope-type nano device for siRNA.
    Nakamura Y; Kogure K; Futaki S; Harashima H
    J Control Release; 2007 Jun; 119(3):360-7. PubMed ID: 17478000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficient short interference RNA delivery to tumor cells using a combination of octaarginine, GALA and tumor-specific, cleavable polyethylene glycol system.
    Sakurai Y; Hatakeyama H; Akita H; Oishi M; Nagasaki Y; Futaki S; Harashima H
    Biol Pharm Bull; 2009 May; 32(5):928-32. PubMed ID: 19420766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pH-sensitive fusogenic peptide facilitates endosomal escape and greatly enhances the gene silencing of siRNA-containing nanoparticles in vitro and in vivo.
    Hatakeyama H; Ito E; Akita H; Oishi M; Nagasaki Y; Futaki S; Harashima H
    J Control Release; 2009 Oct; 139(2):127-32. PubMed ID: 19540888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The transfection activity of R8-modified nanoparticles and siRNA condensation using pH sensitive stearylated-octahistidine.
    Toriyabe N; Hayashi Y; Harashima H
    Biomaterials; 2013 Jan; 34(4):1337-43. PubMed ID: 23141897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significant and prolonged antisense effect of a multifunctional envelope-type nano device encapsulating antisense oligodeoxynucleotide.
    Nakamura Y; Kogure K; Yamada Y; Futaki S; Harashima H
    J Pharm Pharmacol; 2006 Apr; 58(4):431-7. PubMed ID: 16597360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanoparticles for ex vivo siRNA delivery to dendritic cells for cancer vaccines: programmed endosomal escape and dissociation.
    Akita H; Kogure K; Moriguchi R; Nakamura Y; Higashi T; Nakamura T; Serada S; Fujimoto M; Naka T; Futaki S; Harashima H
    J Control Release; 2010 May; 143(3):311-7. PubMed ID: 20080139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multifunctional envelope-type nano device for novel gene delivery of siRNA plasmids.
    Moriguchi R; Kogure K; Akita H; Futaki S; Miyagishi M; Taira K; Harashima H
    Int J Pharm; 2005 Sep; 301(1-2):277-85. PubMed ID: 16019173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Octaarginine- and pH sensitive fusogenic peptide-modified nanoparticles for liver gene delivery.
    Khalil IA; Hayashi Y; Mizuno R; Harashima H
    J Control Release; 2011 Dec; 156(3):374-80. PubMed ID: 21864599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Development of a novel artificial gene delivery system multifunctional envelope-type nano device for gene therapy].
    Kogure K
    Yakugaku Zasshi; 2007 Oct; 127(10):1685-91. PubMed ID: 17917425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reducing the Cytotoxicity of Lipid Nanoparticles Associated with a Fusogenic Cationic Lipid in a Natural Killer Cell Line by Introducing a Polycation-Based siRNA Core.
    Nakamura T; Yamada K; Fujiwara Y; Sato Y; Harashima H
    Mol Pharm; 2018 Jun; 15(6):2142-2150. PubMed ID: 29668291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stearylated INF7 peptide enhances endosomal escape and gene expression of PEGylated nanoparticles both in vitro and in vivo.
    El-Sayed A; Masuda T; Akita H; Harashima H
    J Pharm Sci; 2012 Feb; 101(2):879-82. PubMed ID: 22086751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reprint of: Nanoparticles for ex vivo siRNA delivery to dendritic cells for cancer vaccines: Programmed endosomal escape and dissociation.
    Akita H; Kogure K; Moriguchi R; Nakamura Y; Higashi T; Nakamura T; Serada S; Fujimoto M; Naka T; Futaki S; Harashima H
    J Control Release; 2011 Jan; 149(1):58-64. PubMed ID: 20826039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Development of an efficient short interference RNA (siRNA) delivery system with a new pH-sensitive cationic lipid].
    Sato Y; Hatakeyama H; Hyodo M; Akita H; Harashima H
    Yakugaku Zasshi; 2012; 132(12):1355-63. PubMed ID: 23208041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pH-sensitive cationic lipid facilitates the delivery of liposomal siRNA and gene silencing activity in vitro and in vivo.
    Sato Y; Hatakeyama H; Sakurai Y; Hyodo M; Akita H; Harashima H
    J Control Release; 2012 Nov; 163(3):267-76. PubMed ID: 23000694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyaluronic acid controls the uptake pathway and intracellular trafficking of an octaarginine-modified gene vector in CD44 positive- and CD44 negative-cells.
    Yamada Y; Hashida M; Harashima H
    Biomaterials; 2015 Jun; 52():189-98. PubMed ID: 25818425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic delivery of siRNA to tumors using a lipid nanoparticle containing a tumor-specific cleavable PEG-lipid.
    Hatakeyama H; Akita H; Ito E; Hayashi Y; Oishi M; Nagasaki Y; Danev R; Nagayama K; Kaji N; Kikuchi H; Baba Y; Harashima H
    Biomaterials; 2011 Jun; 32(18):4306-16. PubMed ID: 21429576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conjugates of HA2 with octaarginine-grafted HPMA copolymer offer effective siRNA delivery and gene silencing in cancer cells.
    Golan M; Feinshtein V; David A
    Eur J Pharm Biopharm; 2016 Dec; 109():103-112. PubMed ID: 27702685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced gene expression by a novel stearylated INF7 peptide derivative through fusion independent endosomal escape.
    El-Sayed A; Masuda T; Khalil I; Akita H; Harashima H
    J Control Release; 2009 Sep; 138(2):160-7. PubMed ID: 19465073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endosomal escape and the knockdown efficiency of liposomal-siRNA by the fusogenic peptide shGALA.
    Sakurai Y; Hatakeyama H; Sato Y; Akita H; Takayama K; Kobayashi S; Futaki S; Harashima H
    Biomaterials; 2011 Aug; 32(24):5733-42. PubMed ID: 21605898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.